U.S. Advance Wound Care Market – Industry Trends and Forecast to 2026
Short Description
By Product Type (Dressings, Therapy Devices, Biologics), Wound Type (Surgical Wound, Diabetic Ulcers, Burns, Pressure Ulcers, Venous Ulcers, Others), End-User (Hospitals, Wound Care Centers, Ambulatory Centers, Home Healthcare, Clinics, Community Healthcare), Distribution Channel (Direct Tenders, Retail)
Market Definition:
Wound is an injury/damage/disruption to tissue/cell, wound can be occur due to pressure injuries or bed sores, skin trauma injuries, surgical site infection, burns, untreated injuries (in diabetes), trophic ulcers or other traumas. Advance wound care helps to treat wounds with the help of dressing, biologics and therapy devices. In advance wound care different methods are used to treat wound in different healing stages such as inflammatory stage, fibroblastic stage, and maturation stage by using dressing, biologics and therapy devices.
Market Segmentation
The U.S. advanced wound care market is segmented into four notable segments which are on the basis of product type, wound type, end-user and distribution channel.
• On the basis of product type, the market is segmented into dressings, therapy devices and biologics.
• On the basis of wound type, the market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers, others.
• On the basis of end-user, the market is segmented into hospitals, wound care centres, ambulatory centers, home healthcare, clinics and community healthcare.
• On the basis of distribution channel, the market is segmented into direct tenders, retail.
Market Players
The key market players in U.S. advanced wound care market are:
• KCI Licensing, Inc. (Subsidiary of ACELITY L.P. INC)
• Smith and Nephew
• Medline Industries, Inc
• 3M
• ConvaTec Group PLC
• Medtronic
• Mölnlycke Health Care AB
• Advancis Medical
• PAUL HARTMANN AG
• Integra LifeSciences Corporation
• Organogenesis Holdings Inc.
• Coloplast Group
• B. Braun Melsungen AG
• Baxter
• Johnson & Johnson Services, Inc.
• Anika Therapeutics, Inc.
• ACell, Inc
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of U.S. Advanced Wound Care Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 U.S. Advanced Wound Care Market: Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Primary Interviews With Key Opinion Leaders
- 2.7 Dbmr Market Position Grid
- 2.8 Dbmr Vendor Share Analysis
- 2.9 Multivariate Modeling
- 2.10 Products Lifeline Curve
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Rapid Growth In The Geriatric Population
- 3.1.2 Increasing Number Of Road Accidents And Trauma Injuries
- 3.1.3 Developments And Innovations Of New Products
- 3.1.4 Increasing Surgical Procedures
- 3.2 Restraints
- 3.2.1 Risk Associated With Products
- 3.2.2 High Cost
- 3.3 Opportunities
- 3.3.1 Strategic Initiatives Of The Market Players
- 3.3.2 Potential Application Of Stem Cell Therapy In Wound Care
- 3.3.3 Increasing Research In The Field Of Advanced Wound Care
- 3.4 Challenges
- 3.4.1 Product Recalls
- 4 Executive Summary
- 5 Premium Insights
- 6 Regulatory Scenario
- 7 U.S. Advanced Wound Care Market, By Product Type
- 7.1 Overview
- 7.2 Dressings
- 7.2.1 Film Dressings
- 7.2.1.1 Transparent
- 7.2.1.2 Non Transparent
- 7.2.2 Foam Dressings
- 7.2.3 Hydrogels
- 7.2.4 Alginates
- 7.2.5 Wound Contact Layer
- 7.2.6 Super Absorbent Dressing
- 7.3 Biologics
- 7.3.1 Allografts
- 7.3.1.1 Human Dermal Layer
- 7.3.1.2 Cultured Allografts
- 7.3.2 Synthetic Skin Grafts
- 7.3.3 Xenografts
- 7.3.4 Growth Factors
- 7.3.4.1 Platelet Derived Growth Factor (Pdgf)
- 7.3.4.2 Platelet Rich Plasma (Prp)
- 7.3.4.3 Epidermal Growth Factors (Egf)
- 7.3.4.4 Basic Fibroblast Growth Factors (Bfgf)
- 7.3.4.5 Granulocyte Colony Stimulating Factor (G-csf)
- 7.3.4.6 Talactoferrin Alfa
- 7.3.4.7 Thrombin Peptide (Tp508)
- 7.3.4.8 Keratinocyte Growth Factor (Kgf)
- 7.4 Therapy Devices
- 7.4.1 Negative Pressure Wound Therapy (Npwt)
- 7.4.2 U.S Negative Pressure Wound Therapy (Npwt) In
- 7.4.2.1 Portable Npwt Devices
- 7.4.2.2 Disposable Npwt Devices
- 7.4.2.3 Standalone Npwt Devices
- 7.4.3 Pressure Relief Devices
- 7.4.3.1 Mattress
- 7.4.3.2 Bed
- 7.4.4 Hyperbaric Oxygen Chambers
- 7.4.4.1 Monoplace
- 7.4.4.2 Multiplace
- 7.4.4.3 Topical
- 7.4.5 Wound Debridement Devices
- 7.4.5.1 Hydrosurgical
- 7.4.5.2 Ultrasound
- 7.4.5.3 Mechanical
- 7.4.5.4 Others
- 7.4.6 Physical Therapies
- 7.4.6.1 Laser Therapy
- 7.4.6.2 Electrical Stimulation
- 7.4.6.3 External Shock Wave Therapies
- 7.4.6.4 Saline Mist Therapy
- 8 U.S. Advanced Wound Care Market, By Wound Type
- 8.1 Overview
- 8.2 Surgical Wound
- 8.3 Diabetic Ulcers
- 8.4 Burns
- 8.5 Pressure Ulcers
- 8.6 Venous Ulcers
- 8.7 Others
- 9 U.S. Advanced Wound Care Market, By End User
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Wound Care Centers
- 9.4 Ambulatory Centers
- 9.5 Home Healthcare
- 9.6 Clinics
- 9.7 Community Healthcare
- 10 U.S. Aduanced Wound Care Market, By Distribution Channel
- 10.1 Direct Tenders
- 10.2 Retail
- 11 U.S. Advanced Wound Care Market, Company Landscape
- 11.1 Company Share Analysis: U.S.
- 12 Company Profiles
- 12.1 Kci Licensing, Inc.( Subsidiary Of Acelity L.P. Inc )
- 12.1.1 Company Snapshot
- 12.1.2 Product Portfolio
- 12.1.3 Recent Developments
- 12.2 Smith & Nephew
- 12.2.1 Company Snapshot
- 12.2.2 Revenue Analysis
- 12.2.3 Product Portfolio
- 12.2.4 Recent Developments
- 12.3 Molnlycke Health Care Ab
- 12.3.1 Company Snapshot
- 12.3.2 Recent Developments
- 12.4 3m
- 12.4.1 Company Snapshot
- 12.4.2 Product Portfolio
- 12.4.3 Recent Development
- 12.5 Convatec Group Plc
- 12.5.1 Company Snapshot
- 12.5.2 Revenue Analysis
- 12.5.3 Product Portfolio
- 12.5.4 Recent Developments
- 12.6 Medline Industries, Inc
- 12.6.1 Company Snapshot
- 12.6.2 Product Portfolio
- 12.6.3 Recent Developments
- 12.7 Acell, Inc
- 12.7.1 Company Snapshot
- 12.7.2 Product Portfolio
- 12.7.3 Recent Developments
- 12.8 Advancis Medical Usa Llc
- 12.8.1 Company Snapshot
- 12.8.2 Product Portfolio
- 12.9 Anika Therapeutics, Inc.
- 12.9.1 Company Snapshot
- 12.9.2 Revenue Analysis
- 12.9.3 Product Portfolio
- 12.9.4 Recent Development
- 12.10 B. Braun Melsungen Ag
- 12.10.1 Company Snapshot
- 12.10.2 Revenue Analysis
- 12.10.3 Product Portfolio
- 12.10.4 Recent Development
- 12.11 Baxter
- 12.11.1 Company Snapshot
- 12.11.2 Revenue Analysis
- 12.11.3 Product Portfolio
- 12.12 Coloplast Group
- 12.12.1 Company Snapshot
- 12.12.2 Revenue Analysis
- 12.12.3 Product Portfolio
- 12.12.4 Recent Developments
- 12.13 Integra Lifesciences Corporation
- 12.13.1 Company Snapshot
- 12.13.2 Revenue Analysis
- 12.13.3 Recent Developments
- 12.14 Johnson & Johnson Services, Inc.
- 12.14.1 Company Snapshot
- 12.14.2 Revenue Analysis
- 12.14.3 Product Portfolio
- 12.14.4 Recent Developments
- 12.15 Medtronic
- 12.15.1 Company Snapshot
- 12.15.2 Revenue Analysis
- 12.15.3 Product Portfolio
- 12.15.4 Recent Development
- 12.16 Organogenesis Holdings Inc.
- 12.16.1 Company Snapshot
- 12.16.2 Revenue Analysis
- 12.16.3 Product Portfolio
- 12.16.4 Recent Developments
- 12.17 Paul Hartmann Ag
- 12.17.1 Company Snapshot
- 12.17.2 Product Portfolio
- 12.17.3 Recent Developments
- 13 Questionnaire
- 14 Related Reports
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook